ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - POSITIVE TOP-LINE RESULTS FROM NVK002 TWO-YEAR PHASE III CLINICAL TRIAL (CHINA CHAMP) IN CHINA FOR THE TREATMENT OF MYOPIA PROGRESSION IN CHILDREN
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF TAB014 PHASE III CLINICAL TRIAL LAST PATIENT LAST VISIT IN CHINA
ZHAOKE OPHTH-B: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM
ZHAOKE OPHTH-B: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM
ZHAOKE OPHTH-B: 2024 Interim Report
ZHAOKE OPHTH-B: INSIDE INFORMATION - MARKETING AUTHORIZATION FORBIMATOPROST EYE DROP OBTAINED FROM THENATIONAL MEDICAL PRODUCTS ADMINISTRATION
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
ZHAOKE OPHTH-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
ZHAOKE OPHTH-B: NOTICE OF BOARD MEETING
ZHAOKE OPHTH-B: PROFIT ALERT - REDUCTION IN LOSS
ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR PHASE III CLINICAL TRIAL OF CYCLOSPORINE A (CsA) OPHTHALMIC GEL BY NMPA AND COMPLETION OF NVK002 PHASE III CHINA-CHAMP LAST PATIENT LAST VISIT IN CHINA
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
ZHAOKE OPHTH-B: GRANT OF SHARE OPTIONS
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
ZHAOKE OPHTH-B: POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 17, 2024
ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
ZHAOKE OPHTH-B: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM
No Data
No Data